REG - Indivior PLC - Indivior to Participate in Upcoming Events

IndiviorAnnouncement

16/05/2024 08:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240516:nRSP6967Oa&default-theme=true

RNS Number : 6967O  Indivior PLC  16 May 2024

 

 

Indivior To Participate in Upcoming Investor Events

Slough, UK, and Richmond, VA, May 16, 2024 - Indivior PLC (LSE/NASDAQ: INDV)
today announced that it will participate in the following investor events:

·    21(st) Annual Craig-Hallum Institutional Investor Conference -
Minneapolis, MN

Indivior Management will host 1x1 / Group meetings on Wednesday May 29(th),
2024.  Interested investors should contact their Craig-Hallum representative
to schedule a meeting.

 

·    Jefferies Global Healthcare Conference - New York City, NY

Mark Crossley, Chief Executive Officer, will host a presentation on Wednesday
June 5(th), 2024 at 8:30 a.m. US EST.  The presentation will be publicly
available and can be viewed using the following weblink:

Webcast link (https://wsw.com/webcast/jeff302/indv.l/2066224)

 

 

About Indivior

Indivior is a global pharmaceutical company working to help change patients'
lives by developing medicines to treat substance use disorders (SUD) and
serious mental illnesses. Our vision is that all patients around the world
will have access to evidence-based treatment for the chronic conditions and
co-occurring disorders of SUD. Indivior is dedicated to transforming SUD from
a global human crisis to a recognized and treated chronic disease. Building on
its global portfolio of opioid use disorder treatments, Indivior has a
pipeline of product candidates designed to both expand on its heritage in this
category and potentially address other chronic conditions and cooccurring
disorders of SUD. Headquartered in the United States in Richmond, VA, Indivior
employs more than 1,100 individuals globally and its portfolio of products is
available in 37 countries worldwide. Visit www.indivior.com
(http://www.indivior.com) to learn more. Connect with Indivior on LinkedIn by
visiting www.linkedin.com/company/indivior
(http://www.linkedin.com/company/indivior) .

 

Contact:

Jason Thompson

Vice President, Investor Relations

Tel: 804-402-7123 or jason.thompson@indivior.com
(mailto:jason.thompson@indivior.com)

 

Tim Owens

Director, Investor Relations

Tel: 804-263-3978 or timothy.owens@indivior.com
(mailto:timothy.owens@indivior.com)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCFIFSREAIRLIS